LEP and metabolic dysfunction-associated steatotic liver disease: For instance, three of the genetic models of NAFLD have mutations in either leptin (ob/ob mice) or its receptor (db/db mice and fa/fa Zucker rats) and develop massive obesity, type 2 diabetes, dyslipidemia and the aforementioned fatty liver [92,93,94].